GJB2 hearing loss is the most common inherited cause of deafness worldwide, and it comes from changes in a single gene the inner ear depends on.1PubMed Central. In Vitro Models of GJB2-Related Hearing Loss Recapitulate Ca2+ Transients via a Gap Junction Characteristic of Developing Cochlea It usually affects hearing alone, with no other health problems, and it is typically present from birth. Most children who have it are born to parents who hear perfectly well, because the gene is usually passed down silently. Finding the cause often answers a family’s first question and points to what can be expected next.
What the GJB2 Gene Does in the Ear
GJB2 holds the instructions for connexin 26, a protein that forms small channels linking neighboring cells in the cochlea, the inner ear’s hearing organ.2PubMed. Regulatory mechanisms of connexin26 These channels let potassium and other signaling molecules pass from cell to cell.3PubMed. Regulatory mechanisms of connexin26 That matters because each time sound activates the hearing cells, potassium flows into them and must be carried away through supporting cells and back into the fluid it came from.4PubMed. Potassium ion recycling pathway via gap junction systems in the mammalian cochlea and its interruption in hereditary nonsyndromic deafness
Without working connexin 26, potassium is thought to build up around the hearing cells and poison them.5PubMed. Connexins, hearing and deafness: clinical aspects of mutations in the connexin 26 gene The channels may do more than move potassium, and their full job is still not completely understood.6PubMed Central. Gap junction-mediated intercellular biochemical coupling in cochlear supporting cells is required for normal cochlear functions In animals, losing the gene very early in life causes more severe hearing loss than losing it later, which shows it matters most while the ear is developing.7PubMed Central. GJB2 gene therapy and conditional deletion reveal developmental stage-dependent effects on inner ear structure and function
The damage sits in the inner ear, not the ear canal. This is sensorineural hearing loss, meaning the problem lies in the inner ear rather than a blockage. Hearing aids or implants can help, but ear tubes or wax removal won’t.
The ear looks normal from outside and during an ear exam, and a GJB2 change usually leaves the inner ear’s structure intact. That is why a baby can look and act typically at birth, why the newborn screen, which measures the ear’s response to sound, is what first raises the question, and why genetic testing rather than an ear exam confirms the specific cause.
How GJB2 Hearing Loss Is Inherited
Everyone has two copies of GJB2, one from each parent. The common form of GJB2 hearing loss appears only when both copies are changed.8PubMed Central. DFNB1 Non-syndromic Hearing Impairment: Diversity of Mutations and Associated Phenotypes A person with one changed copy is a carrier. Carriers hear normally and usually never know.
Genetic reports may call this type DFNB1, the label for recessive hearing loss from this gene region.9PubMed Central. Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss The two changed copies can be the same change or two different ones, and either way causes hearing loss.10PubMed Central. DFNB1 Non-syndromic Hearing Impairment: Diversity of Mutations and Associated Phenotypes
Each parent passes on only one of their two copies, and which one is a matter of chance. A carrier parent hands on the changed copy about half the time, so a child must receive it from both parents to have hearing loss. Carrier parents often find out only after a child is diagnosed, so there is frequently no earlier deafness in the family history.
When both parents are carriers, each pregnancy has a 1 in 4 chance of a child with hearing loss, a 1 in 2 chance of a carrier, and a 1 in 4 chance of a child with neither. The odds reset with every pregnancy, so having one affected child doesn’t change the next child’s chances.
For relatives, a carrier result has clear limits. Hearing siblings of an affected child have about a 2 in 3 chance of being carriers. Carriers face a risk only if their partner is also a carrier, and relatives can ask for carrier testing before planning a family.
Finding only one change in a child with hearing loss does not automatically rule GJB2 out, since a second change may sit in a spot the test did not cover. Sometimes a child has one changed GJB2 copy plus a deletion in the neighboring GJB6 gene, which makes connexin 30, and this combination also causes deafness.11PubMed. A deletion involving the connexin 30 gene in nonsyndromic hearing impairment So a test that finds only one GJB2 change may need GJB6 checked too, or the lab may look at the whole gene.
How Common GJB2 Carriers Are
- Europeans: about 1 in 51 carry the 35delG change, nearly 1 in 35 in southern Europe and 1 in 79 in the north.12PubMed. High carrier frequency of the 35delG deafness mutation in European populations
- Ashkenazi Jewish people: about 4 in 100 carry the 167delT change.13PubMed. Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness
- East Asians: about 1 in 100 carry the 235delC change.14PubMed. Evidence of a founder effect for the 235delC mutation of GJB2 (connexin 26) in east Asians
In some populations GJB2 accounts for up to half of all inherited hearing loss that affects hearing alone.15PubMed Central. In Vitro Models of GJB2-Related Hearing Loss Recapitulate Ca2+ Transients via a Gap Junction Characteristic of Developing Cochlea Specific changes trace back to shared ancestors in each region, so each group has its own common variant.16PubMed. Evidence of a founder effect for the 235delC mutation of GJB2 (connexin 26) in east Asians A carrier rate counts people with one changed copy, who hear normally, so it is much higher than the share of people who are deaf from GJB2.
The figures cover only a few well-studied groups. People from other backgrounds can carry GJB2 changes too, often different ones, and with mixed ancestry a single group’s number may not fit well. A negative carrier test for a common change lowers the chance of being a carrier but does not make it zero, because rarer changes can be missed. A family history of childhood hearing loss deserves a conversation with a genetic counselor whatever your background.
How Severe It Is and Whether It Gets Worse
Hearing loss is most severe when both copies carry a change that cuts the protein short, and mildest when neither does.17PubMed. Connexin-26-associated deafness: phenotypic variability and progression of hearing loss Some common changes, such as V37I and M34T, usually cause mild to moderate loss.18PubMed Central. GJB2 mutations and degree of hearing loss: a multicenter study The type of change can’t predict any one child’s hearing exactly, though.19PubMed Central. Hearing and Hearing Loss Progression in Patients with GJB2 Gene Mutations: A Long-Term Follow-Up The GJB2–GJB6 combination tends to cause especially profound loss.20PubMed Central. GJB2 mutations and degree of hearing loss: a multicenter study
Audiologists describe loss in levels from mild to profound, based on the quietest sounds a child can detect at different pitches. These appear on a hearing chart, which you can ask the audiologist to walk you through. Two children with the same GJB2 change can land at different levels, so the label comes from the child’s own test, not the gene result.
Mild loss is easy to underestimate. A child can seem to hear fine at home, in quiet and up close. Trouble tends to show in noisy places such as classrooms, in group conversation, or when the speaker is far away or facing away. Hearing loss that goes unnoticed can still slow speech and language.
Hearing can also change over time. About 1 in 4 children with GJB2 loss had hearing that measurably worsened over repeat tests.21PubMed. Connexin-26-associated deafness: phenotypic variability and progression of hearing loss Some babies who passed newborn screening were later found to have hearing loss.22PubMed. Connexin-26-associated deafness: phenotypic variability and progression of hearing loss Regular hearing tests through childhood are worth keeping up.
Balance is usually spared. Balance tests are typically normal, and the inner-ear structure is generally not abnormal.23PubMed. Vestibular function and temporal bone imaging in DFNB1
When GJB2 Affects the Skin Too
A few specific GJB2 changes act dominantly, meaning one copy alone causes problems.24PubMed Central. Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome These can cause hearing loss with thickened skin on the palms and soles, or KID syndrome, which adds eye inflammation and scaly skin.25PubMed Central. Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome KID syndrome is rare.26DermatologÃa Argentina. SÃndrome KID con mutación p.Asp50Asn en el GJB2 An affected parent has a 1 in 2 chance of passing it to each child.
A child with a dominant change might develop thick skin on the palms and soles, sometimes in the first years of life. With KID syndrome, skin changes and eye irritation typically appear in early childhood. Parents who notice these along with hearing loss should mention them to the doctor, since they point to a different diagnosis.
How GJB2 Hearing Loss Is Diagnosed
When a baby fails the newborn hearing screen, there is a real chance GJB2 is the cause.27PubMed. Evaluation of newborn screening bloodspot-based genetic testing as second tier screen for bedside newborn hearing screening The blood spot already taken at birth can be tested for common GJB2 changes.28PubMed. Evaluation of newborn screening bloodspot-based genetic testing as second tier screen for bedside newborn hearing screening Genetic screening has also found some babies with GJB2 loss who had passed their hearing screen.29PubMed Central. The Importance of Newborn Genetic Screening for Early Identification of GJB2 and SLC26A4 Related Hearing Loss
A failed screen means the baby did not show the expected response to sound at that test, not that hearing loss is confirmed. Fluid left in the ear after birth or a noisy test can cause a fail, which is why a repeat is standard. The usual path is a repeat screen, then a full hearing test by an audiologist. If hearing loss is confirmed, a referral to genetics follows, and a genetic counselor explains the results and family risk.
The genetic test usually needs only a small sample of blood or saliva from the child, or in some programs the blood spot already on file. Results can take days to weeks depending on the lab and how many genes are read. Many labs read GJB2 as part of a larger panel of hearing loss genes, which helps when GJB2 is negative.
If GJB2 is negative, the next most common genetic cause is often the STRC gene, with others less common.30PubMed. Spectrum and frequencies of non GJB2 gene mutations in Czech patients with early non-syndromic hearing loss detected by gene panel NGS and whole-exome sequencing Parents usually find a clear GJB2 result helpful, though those with unclear results still see some benefit.31PubMed Central. A Prospective, Longitudinal Study of the Impact of GJB2/GJB6 Genetic Testing on the Beliefs and Attitudes of Parents of Deaf and Hard-of-Hearing Infants
Hearing Aids and Cochlear Implants for GJB2
Children with GJB2 loss understand speech after a cochlear implant as well as other implanted children.32PubMed. Cochlear implantation for children with GJB2-related deafness Those implanted before about 3.5 years showed better hearing and speech scores than other children at 3 and 5 years.33PubMed Central. Long-Term Cochlear Implant Outcomes in Children with GJB2 and SLC26A4 Mutations GJB2 damages the inner ear but usually leaves the hearing nerve working, which is what an implant relies on.
A hearing aid makes sound louder for an ear that still has working hearing cells. A cochlear implant skips the damaged cells and stimulates the hearing nerve directly with tiny electrical signals through wires placed inside the cochlea. That is why an implant can help when loud sound still isn’t clear enough with aids.
Mild or moderate loss usually starts with hearing aids, and an implant is considered when aids give too little benefit. Early hearing access supports language, whether spoken or signed.
The team usually tests hearing with aids first, checks how much benefit they give, and then assesses whether an implant is likely to do better. Imaging of the ear helps the surgeon plan. The operation is done under anesthesia, and the device is switched on some weeks later, once healing is complete.
An implant gives useful hearing but not normal hearing, and therapy after implanting matters. Many families also use sign language.
Is Gene Therapy for GJB2 Coming
Not yet. In mice, delivering a working gene restored the ear’s cell channels and reduced cell death, but did not improve hearing.34Gene Therapy. Virally expressed connexin26 restores gap junction function in the cochlea of conditional Gjb2 knockout mice A gene-editing approach fixed one dominant change in the channels of mouse cells.35PubMed Central. AAV-mediated base editing restores cochlear gap junction in GJB2 dominant-negative mutation-associated syndromic hearing loss model These treatments are not available for people, and current care relies on hearing aids and implants.
Timing will likely matter too. The gene matters most while the ear develops, so a future therapy may need to be given very early. Families shouldn’t delay implants while waiting for gene therapy.

